Massive extracorporeal blood clotting during discontinuous flow leukapheresis.
A case is reported in which massive extracorporeal blood clotting necessitated the discontinuance of leukapheresis and loss of the product. An investigation of the cause of the massive clotting is reported along with suggested precautions to prevent similar occurrences in pheresis programs.
D000925:Anticoagulants / Q000494:pharmacology; D001777:Blood Coagulation; D002951:Citrates / Q000494:pharmacology; D006801:Humans; D010956:Plasmapheresis
D000925:Anticoagulants; D002951:Citrates